Richard Bonnet

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

53h-index11.4kcitations261works9.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Resistance in Bacteria(134), Gut microbiota and health(45), Escherichia coli research studies(36), Pharmaceutical and Antibiotic Environmental Impacts(30), Bacterial biofilms and quorum sensing(30)

Publications261 total

Comparison of three immunochromatographic assays for the rapid detection of CTX-M in Enterobacterales
European Journal of Clinical Microbiology & Infectious Diseases·2025· 1 cited
Bla producing Pseudomonas aeruginosa ST235 is involved in resistance to different β-lactams
Microbial Pathogenesis·2025Open Access
Evaluation of imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam and cefepime-zidebactam activities on a wide collection of French clinical Enterobacterales isolates
Diagnostic Microbiology and Infectious Disease·2025Open Access
Mutational Analysis of Colistin-Resistant Pseudomonas aeruginosa Isolates: From Genomic Background to Antibiotic Resistance
Pathogens·2025· 2 citedOpen Access
No genetic link between E. coli isolates carrying mcr-1 in bovines and humans in France
Journal of Global Antimicrobial Resistance·2025· 2 citedOpen Access
Comparison of Crohn’s disease-associated adherent-invasive <i>Escherichia coli</i> (AIEC) from France and Hong Kong: results from the Pacific study
Gut Microbes·2024· 3 citedOpen Access
Occurrence of in vivo carbapenem-resistant Campylobacter coli mediated by porA point mutation and overexpression of blaOXA-489 under meropenem treatment
Clinical Microbiology and Infection·2024· 2 cited
MAST® D72C test: a novel option for ESBL, AmpC and carbapenemase detection
European Journal of Clinical Microbiology & Infectious Diseases·2024· 3 cited
Global transmission of extended-spectrum cephalosporin resistance in Escherichia coli driven by epidemic plasmids
EBioMedicine·2024· 23 citedOpen Access
The Colibactin-Producing Escherichia coli alters the tumor microenvironmentto immunosuppressive lipid overload facilitating colorectal cancer progressionand chemoresistance.
SPIRE - Sciences Po Institutional REpository·2024
The colibactin-producing <i>Escherichia coli</i> alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance
Gut Microbes·2024· 53 citedOpen Access
Colibactin-producing <i>Escherichia coli</i> enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence
Gut Microbes·2024· 29 citedOpen Access
Combined genomic-proteomic approach in the identification of Campylobacter coli amoxicillin-clavulanic acid resistance mechanism in clinical isolates
Frontiers in Microbiology·2023· 4 citedOpen Access
ABRomics: an integrated multi-omics platform for antibiotic resistance research and public health
HAL (Le Centre pour la Communication Scientifique Directe)·2023Open Access
Host-microbiota relationship in the pathophysiology of aseptic abscess syndrome: protocol for a multicentre case-control study (ABSCESSBIOT)
BMJ Open·2023· 3 citedOpen Access
ABRomics - an open access online platform on antimicrobial resistance to store, integrate, analyze and share multi-omics data
HAL (Le Centre pour la Communication Scientifique Directe)·2023Open Access
Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing <i>Escherichia coli</i> in <i> Apc <sup>Min/+</sup> </i> mice
Gut Microbes·2023· 12 citedOpen Access
Mo1799 COMPARISON OF CROHN'S DISEASE-ASSOCIATED ADHERENT-INVASIVE ESCHERICHIA COLI (AIEC) FROM FRANCE AND HONG-KONG: RESULTS FROM THE PACIFIC STUDY
Gastroenterology·2023· 1 cited
Supplementary Figures 1 - 3 from Colonization of the Human Gut by &lt;i&gt;E. coli&lt;/i&gt; and Colorectal Cancer Risk
2023Open Access
Supplementary Figure Legend from Colonization of the Human Gut by &lt;i&gt;E. coli&lt;/i&gt; and Colorectal Cancer Risk
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Julien Delmas(15), Guillaume Dalmasso(12), Arlette Darfeuille–Michaud(11), J. Sirot(11), Frédéric Robin(9), Nicolas Barnich(9), Christophe de Champs(9), D. Sirot(9), C. Chanal(9), Brian K. Shoichet(8), Damien Dubois(7), Pierre Sauvanet(6), Lucie Gibold(6), Racha Beyrouthy(6), Antony Cougnoux(5), Roger Labia(5), Denis Pezet(4), Tiphanie Faïs(4), Yu Chen(4), Éric Oswald(4)